Sirolimus and Familial Adenomatous Polyposis (FAP) | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Sirolimus and Familial Adenomatous Polyposis (FAP)

key information

study id #: NCT03095703

condition: Adenomatous Polyposis Coli

status: completed


The aim of the study is to investigate the effect of sirolimus on the progression of intestinal adenomas in patients with FAP and to assess the safety of this treatment.

intervention: Drug: Sirolimus

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.